Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019

Kathryn R Tringale; Harper Hubbeling; Fumiko Chino; Carla Hajj; Joachim Yahalom; Brandon S Imber

doi:10.1001/jamahealthforum.2022.1815

Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019

JAMA Health Forum. 2022 Jul 1;3(7):e221815. doi: 10.1001/jamahealthforum.2022.1815. eCollection 2022 Jul.

Authors

Kathryn R Tringale¹, Harper Hubbeling¹, Fumiko Chino¹, Carla Hajj¹, Joachim Yahalom¹, Brandon S Imber¹

Affiliation

¹ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Abstract

This cross-sectional study uses Centers for Medicare & Medicaid Services payment data to examine use of short-course radiotherapy from 2015 to 2019 among Medicare beneficiaries with indolent lymphoma.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Cross-Sectional Studies
Humans
Lymphoma* / radiotherapy
Medicare*
United States / epidemiology

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States